Historical information

Provera is used to treat endometriosis, the absence of menstrual periods (not due to pregnancy), abnormal bleeding from the uterus, certain types of cancer including cancer of the breast, kidney and endometrium, and in combination with an estrogen containing medicine to relieve symptoms of menopause in women with an intact uterus. (NPS MedicineWise)

Physical description

Two rectangular cardboard boxes containing strips of Provera 5mg tablets. Front of each box is printed with supply and use warnings, as well as the text '28 TABLETS/Provera Tablets/5 mg/Each tablet contains: MEDROXYPROGESTERONE ACETATE 5mg. Front of box is also labelled 'SAMPLE ONLY' and 'NEW/COLOUR/NEW FORMULATION/NEW SHAPE'. Manufacturer logo (Upjohn) at bottom right hand corner of the front of each box. Back of box is printed with dosage instructions, storage instructions, and tablet contents. Manufacturer logo (Upjohn) at bottom left on back of box. one end of box is imprinted with a batch number and an expiry date. Expiry date is 12/97. Tablet strips each contain 28 tablets, in four rows of seven. Front of tablet strip printed with the text 'Provera 5mh Tablets' at centre. Left hand side of tablet strip is printed with the text 'WEEK 1', 'WEEK 2', "WEEK 3', and 'WEEK 4', with each week label corresponding to a row of seven tablets. Abbreviations for the days of the week are printed on tablet strip next to each tablet. Right hand side of tablet strip is stamped with a batch number and an expiry date. Expiry date is 12/97. Tablet strip has silver foil on top surface, and blue foil on bottom surface. Blue foil on bottom of tablet strip printed with the repeated text 'Upjohn/Provera Tablets/MEDROXYPROGESTERONE/ ACETATE 5mg'.